Neuphoria Therapeutics Inc. (NEUP) stock: price, suppliers, customers and institutional ownership
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Neuphoria Therapeutics Inc.'s mission is to develop impactful treatments for neuropsychiatric disorders, bringing new hope and tangible improvements to patients’ lives. They are headquartered in Burlington, MA.
the bull case· 3
22
managers reporting a position in thirteen F filings
13fJun 30 '262 of 15
of the largest reporting managers cut their stake in the latest quarter
13fJun 30 '26+10.01%
change in shares held by the ten largest reporting managers over the latest quarter
13fJun 30 '26the bear case· 1
5
managers whose positions together make up four fifths of the reported value
13fJun 30 '26Sides and captions by the model; every figure is ours. Built Sep 16 '26 for the Sep 30 '26 report. Not a forecast, not advice.
Neuphoria Therapeutics Inc. has no measured co-movers clearing our correlation floor, so only its SEC classification is shown.
SIC 2834, Pharmaceutical Preparations, from each company's own filings. Largest first.
tall tick = annual report · 1 on record
22 managers report a position worth $8.7M between them, and 5 of them hold 80% of it.
NEUP (Neuphoria Therapeutics Inc.) has 0 disclosed suppliers and 1 disclosed customers, strongest disclosure first.
Customers:
Select a tie for its filing sentence; select again to open the company. Nearer the centre, the more the filings disclose. Extended: satellites hang off single companies, not bundled sectors.
Neuphoria Therapeutics Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
No intraday reading yet this session.